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Abstract Cyclotides are a very abundant class of plant
peptides that display significant sequence variability
around a conserved cystine-knot motif and a head-to-tail
cyclized backbone conferring them with remarkable sta-
bility. Their intrinsic bioactivities combined with tools of
peptide engineering make cyclotides an interesting tem-
plate for the design of novel agrochemicals and pharma-
ceuticals. However, laborious isolation and purification
prior to de novo sequencing limits their discovery and
hence their use as scaffolds for peptide-based drug devel-
opment. Here we extend the knowledge about their
sequence diversity by analysing the cyclotide content of a
violet species native to Western Asia and the Caucasus
region. Using an experimental approach, which was named
sequence fragment assembly by MALDI-TOF/TOF, it was
possible to characterize 13 cyclotides from Viola ignobilis,
whereof ten (vigno 1–10) display previously unknown
sequences. Amino acid sequencing of various enzymatic
digests of cyclotides allowed the accurate assembly and
alignment of smaller fragments to elucidate their primary
structure, even when analysing mixtures containing mul-
tiple peptides. As a model to further dissect the combina-
torial nature of the cyclotide scaffold, we employed in vitro
oxidative refolding of representative vigno cyclotides and
confirmed the high dependency of folding yield on the
inter-cysteine loop sequences. Overall this work highlights
the immense structural diversity and plasticity of the
unique cyclotide framework. The presented approach for
the sequence analysis of peptide mixtures facilitates and
accelerates the discovery of novel plant cyclotides.
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Introduction
Cyclotides are a unique class of cysteine-rich macrocyclic
mini-proteins of about 30 amino acids in size that are
defined by a head-to-tail cyclized backbone and three
disulfide bonds in a knotted arrangement referred to as
cyclic cystine-knot (CCK) motif (Craik et al. 1999). Their
knotted structure makes them exceptionally stable against
thermal, chemical and enzymatic degradation (Colgrave
and Craik 2004). Cyclotides have been discovered and
isolated from plants of the violet (Violaceae), coffee (Ru-
biaceae), cucurbit (Cucurbitaceae) and legume family
(Fabaceae) (Poth et al. 2010). Their distribution within the
plant kingdom still remains unclear (Gruber 2010), but they
are expected to be far more widespread and the number of
different cyclotides may be around 50,000 (Gruber et al.
2008; Simonsen et al. 2005) making them one of the largest
peptide classes within plants. In agreement with their
anticipated number, recent studies report the presence of
more than 70 different cyclotides within one single species
(Seydel et al. 2007; Gru¨ndemann et al. 2012). The first
cyclotide kalata B1 was discovered from ‘‘kalata-kalata’’, a
decoction from leaves of Oldenlandia affinis, which has
been used as a remedy during childbirth in African eth-
nomedicine due to its uterotonic activity (Gran 1970;
Gruber and O’Brien 2011). In line with their reported
antibacterial (Tam et al. 1999), antifouling (Go¨ransson
et al. 2004), anthelmintic (Colgrave et al. 2008) and
insecticidal properties (Jennings et al. 2001; Gruber et al.
2007a; Barbeta et al. 2008) their native function seems to
be part of the plant defence system.
As a key feature, cyclotides are amenable to various
amino acid changes by peptide engineering, which high-
lights the flexibility and plasticity of the cyclotide frame-
work (Clark et al. 2006). Thus, their high sequence
diversity is extensively under investigation for being uti-
lized as scaffolds in the development of agrochemicals and
pharmaceuticals (Henriques and Craik 2010). Besides these
distinct differences in the sequences of the so-called inter-
cysteine loops, cyclotides can be divided into two sub-
families, i.e., Mo¨bius or bracelet type cyclotides based on
the presence or absence of a cis-Pro residue in loop 5
(Fig. 1) (Craik et al. 1999). These differences have further
implications regarding their physico-chemical properties.
Whereas most Mo¨bius cyclotides are slightly negatively
charged or have an overall net-charge of zero, bracelet
cyclotides are usually multiply positively charged. This
ultimately influences their chemical behaviour and ame-
nability to sequencing and oxidative folding, which are still
challenges, in particular for bracelet cyclotides.
Usually, amino acid sequencing of cyclotides is per-
formed after enzymatic digestion of peptides that have
been laboriously purified by reversed-phase high
performance liquid chromatography (RP-HPLC) to pro-
duce single linearized peptides that are amenable to tandem
mass spectrometry (MS) analysis. However, the complex-
ity of cyclotide plant extracts, which comprise dozens of
distinct peptides, limits their analysis and characterization
by standard MS analysis. Using endoproteinase GluC
(endo-GluC), cyclotides are mostly cleaved to yield a
single (‘ring-opened’) peptide fragment due to a conserved
glutamic acid in loop 1, whereas the use of trypsin and
chymotrypsin usually yields several fragments due to
multiple cleavage sites. When applied to the analysis of
cyclotide mixtures as they occur in plant extracts, mass
spectra may be confusing and hard to evaluate caused by
fragment ion overlays. Hence the application of combina-
tions of digests to obtain peptide-specific fragments and the
subsequent accurate assembly of sequence fragments may
overcome this issue. Particularly for bracelet cyclotides this
is of importance since until now the majority (*70 %) of
more than 200 published cyclotide sequences accessible on
CyBase (Wang et al. 2008b) belong to this subfamily.
Besides the complexity of cyclotide sequence analysis,
another issue associated with their great diversity is their
chemical and biological synthesis. Previous studies have
shown that different enzymes seem to be involved in
backbone cyclization and disulfide bond formation (Gruber
et al. 2007b; Saska et al. 2007) during biosynthesis of these
gene-encoded peptides in planta. However, the community
still lacks clarity about this process, in particular with
respect to the sequence-folding relationship, i.e., how the
inter-cysteine sequences of different cyclotides can
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Fig. 1 Ribbon structures of the cyclotides kalata B1 (left panel), a
representative of the Mo¨bius subfamily and cycloviolacin O2 (right
panel) belonging to the bracelet subfamily are shown as cartoons. The
unique cyclic cystine-knot (CCK) motif with three conserved
disulfide bonds (yellow) and the cyclized backbone (black dots and
connecting line) as well as typical secondary structure elements of a-
helices (blue) and b-sheets (red) and their respective sequences are
shown (PDB code: 1NB1 and 2KNM, respectively). The disulfide
connectivity CI–IV, CII–V and CIII–VI has been indicated with black
lines (color figure online)
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influence the formation of the native CCK-motif and hence
determine their folding yield. As a consequence, in vitro
oxidative folding is still a major challenge in cyclotide
engineering. Whereas high-yield chemical synthesis and
folding of Mo¨bius cyclotides is possible (Daly et al. 1999),
obtaining correctly folded bracelet cyclotides is much more
difficult and yields of about 10–40 % or less of native
peptide are common (Leta Aboye et al. 2008; Wong et al.
2011). However, chemical synthesis of cyclotides is an
important tool to obtain sufficient peptide material for
bioactivity studies.
Our aim is to characterize plant cyclotides from Viola
ignobilis, a native Iranian species of the violet family that
was recently discovered to contain cyclotides (Hashempour
et al. 2011). As a rich source for representatives of both
cyclotide subfamilies, we analysed cyclotide-containing
fractions using matrix-assisted laser desorption ionization-
time of flight (MALDI-TOF) MS and tandem MS analyt-
ics. Together with the use of different enzymatic digests
and detailed analysis of mass spectra, full peptide sequence
coverage could be achieved by assembling and aligning
various sequence fragments. This approach, which we
called sequence fragment assembly turned out to be a
powerful tool for cyclotide identification and de novo
sequencing even when analysing mixtures. To dissect the
influence of cyclotide sequence variability with respect to
the formation of their native structure, we performed oxi-
dative refolding experiments using representative vigno
(V. ignobilis) cyclotides comprising distinct, but subtle
differences in their inter-cysteine loop sequences. Overall
the characterization of these novel cyclotides highlights
their enormous sequence variability and the proposed
sequencing methodology may overcome limitations in the
discovery of novel representatives of this unique class of
circular plant peptides.
Materials and methods
Plant collection, extraction and RP-HPLC fractionation
Aerial parts of V. ignobilis Rupr. were collected in the
mountains at an altitude of 1,500–2,500 m around the
village of Negarestan in the region of East Azerbaijan
(Iran) in spring 2010. A voucher specimen was identified
and deposited at the Institute of Medicinal Plants and Drug
Research, Iran (MPH-1917). The dried plant material
(*500 g) was ground prior to solvent extraction with a
mixture of MeOH:CH2Cl2 (1:1; v/v) overnight under con-
tinuous agitation at 20 C. After adding of 0.5 volume
water the aqueous phase was concentrated on a rotary
evaporator prior to freeze drying, yielding what is further
referred to as crude extract. The crude extract was
dissolved in 0.1 M NH4HCO3 buffer (pH * 8.1) and
immediately used for solid-phase extraction (SPE). C18
SPE cartridges (Macherey-Nagel, Chromabond; 10 g;
50 mL) were activated with 1 bed volume of MeOH and
subsequently equilibrated with 1 bed volume of aqueous
1 % FA. After application of the extract, the cartridges
were washed with 1 bed volume of 1 % FA. Putative
cyclotide containing fractions of 50 and 80 % EtOH were
collected and freeze dried. After dissolving in 1 % FA they
were fractionated using preparative and semi-preparative
RP-C18 HPLC (Knauer, Eurospher I 5 lm; 250 9 16.1
mm; 100 A˚) using a Knauer 1200 series unit, with an
isocratic flow of 30 % acetonitrile: H2O (v/v) at a flow rate
of 8 mL min-1. Fractions were collected manually by UV
detection at 210 nm. All samples were extracted by
avoiding prolonged exposure to high pH and sample
heating to reduce the risk of Asn deamidation.
Reduction, alkylation and enzymatic digest
Prior to MS analysis, cyclotides were enzymatically
digested to produce linearized fragments following reduc-
tion and alkylation of Cys-residues. Lyophilized samples
(*0.5 lg peptide) were dissolved in 0.1 M NH4HCO3
buffer (pH 8.2) and 20 lL aliquots were reduced by adding
2 lL of 10 mM dithiothreitol and were incubated at 20 C
for 30 min. Alkylation was carried out by adding 4 lL of
100 mM iodoacetamide to the reduced samples and incu-
bating for 10 min at 20 C. After a second incubation step
for 10 min with 1 lL of 10 mM dithiothreitol to quench
the reaction with iodoacetamide, 2 lL of trypsin, endo-
GluC and/or chymotrypsin (all Sigma-Aldrich, Austria) at
concentrations of 0.1–0.5 lg lL-1 were added. All digests
were incubated at 37 C between 3 and 16 h, quenched
with concentrated acetic acid (final concentration 3 %) and
stored at 4 C-20 C until further analysis.
MALDI-TOF/TOF analysis and peptide sequencing
Analysis of crude, reduced/alkylated and digested samples
were performed on a MALDI-TOF/TOF 4800 Analyser
(AB Sciex, Canada) operated in reflector positive ion mode
acquiring 2,000–3,600 total shots per spectrum with a laser
intensity set between 3,200 and 3,800. MS and MS/MS
experiments were carried out using a-cyano-hydroxyl-cin-
namic acid matrix at a concentration of 5 mg mL-1 in
50 % (v/v) acetonitrile. 0.5 lL of each sample was mixed
with 3 lL of matrix solution and the mixture was spotted
onto the target plate. Tandem mass spectra were acquired
using laser energy of 1 kV with and without the use of
collision-induced dissociation and processed using the Data
Explorer Software. Cyclotides were identified by sequence
fragment assembly (as explained below) and manual
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peptide sequencing. Automated database searches using the
ERA-tool (Colgrave et al. 2010) and DeNovoExplorer
software were used to compare manual annotated sequen-
ces. The MS/MS spectra were examined and sequenced
based on assignment of the N-terminal b-ion and C-ter-
minal y-ion series. The disulfide connectivity of CI–IV,
CII–V and CIII–VI was assigned based on homology with
published sequences.
Oxidative refolding of cyclotides
Cyclotides were purified by RP-HPLC on a Dionex Ulti-
mate 3000 HPLC unit (Dionex, Netherlands) using semi-
preparative (250 9 10 mm) and analytical (250 9 4.6
mm) Kromasil C18 columns (5 lm; 100 A˚) with linear
gradients of 0.1–1 % min-1 or isocratic flow of 25–35 %
buffer B (90 % acetonitrile in ddH2O, 0.08 % TFA) at flow
rates of 3 and 1 ml min-1, respectively. The control pep-
tide kalata B1 was isolated from Oldenlandia affinis extract
as described earlier (Gru¨ndemann et al. 2012). The same
procedure was applied for the purification of cycloviolacin
O2 from Viola odorata. Reduction was performed as
described above and stopped after 30 min incubation by
adding concentrated TFA (Sigma-Aldrich, Austria) and
samples were immediately subjected to HPLC purification.
Folding of 60 lL aliquots, containing 2.5–10 lM peptide,
was performed at final concentration of 2 mM reduced
(GSH) and 0.1 mM oxidized (GSSG) glutathione (Sigma-
Aldrich, Austria). Freeze-dried aliquots were resolved in
three different folding-buffers, i.e., 25 and 75 % isopro-
panol (Roth, Germany) and 35 % DMSO/5 % dodecyl-b-
maltoside (DBM) in 0.1 M NH4HCO3 buffer (pH 8.2). For
control experiments with cycloviolacin O2 the folding
conditions included final concentrations of 2 mM GSH and
2 mM cystamine in 35 % DMSO/5 % DBM buffer and GSH/
cystamine (2/2 mM) in 0.1 M Tris–HCl buffer (pH 8.5) at 4 C
and 20 C. Aliquots were analysed at several time points
(15 min, 1 h and 24 h) after incubation at 20 C. Folding
reaction was quenched by adding 1 lL of concentrated TFA
and samples were analysed by RP-HPLC on an Aeris Peptide
XB-C18 (150 9 2.1 mm; 3.6 lm; 100 A˚) column (Phenome-
nex, Germany) at a flow rate of 0.3 ml min-1 with a gradient of
2 % min-1 buffer B. Folding yields were determined using the
peak integration tool of Chromeleon software 6.8 with a peak
detection limit set at 0.07 9 signal (mAU at 214 nm) 9
retention time (min). Folding kinetic graphs and calculations of
rate constant and half-time were prepared using the one-phase
association fit in GraphPad Prism 5 software.
Cyclotide homology modelling
The structural models of vigno 1, 2 and 10 were modelled
using the CycloMod application for cyclotide structure
modelling within Cybase (http://www.cybase.org.au/). The
models were generated using Modeller 9.10 and analysed
by Molprobity (Davis et al. 2007). The percentage of res-
idues in the most favoured Ramachandran region and the
Molprobity scores are: vigno 1 (92.59 % and 2.71), vigno 2
(89.29 % and 2.75) and vigno 10 (89.66 % and 3.27).
Results and discussion
The discovery and hence the pharmaceutical value of cy-
clotides is limited by an efficient and reliable protocol for
peptide sequence analysis, in particular in crude plant
extracts and fractions that contain mixtures of different
cyclotides. Therefore, the main goal of this study was to
describe a robust method for cyclotide sequence charac-
terization using MALDI-TOF/TOF analytics.
Identification of novel cyclotides from Viola ignobilis
Viola ignobilis, a violet plant that frequently occurs in
mountainous regions of Iran has recently been described to
contain cyclotides (Hashempour et al. 2011) and this is
consistent with previous studies showing that all Violaceae
plants analysed to date express this unique class of cyclic
mini-proteins. According to established extraction proto-
cols it was possible to identify and isolate several cyclo-
tide-containing fractions from V. ignobilis. Figure 2 shows
the seven fractions obtained by RP-HPLC fractionation of
the initial two solid-phase extracts. Exemplarily, a
MALDI-TOF spectrum of one fraction (Fig. 2c) indicates
the presence of multiple cyclotides whereas standard
HPLC analysis is not powerful enough to resolve those co-
eluting cyclotides (Fig. 2d). This is a common scenario and
usually requires further purification prior to MS sequenc-
ing. However in the case of low sample amounts, laborious
purification may lead to sample loss and the use of mix-
tures might be inevitable. Hence the aim was to develop a
protocol to perform MALDI-TOF/TOF-based sequence
characterization using semi-pure fractions containing at
least two cyclotides. Subsequently it was possible to
identify 13 cyclotides (vigno 1–10, varv A, cycloviolacin
O2 and cO9) in seven HPLC fractions (Fig. 2a, b).
De novo cyclotide sequencing using ‘sequence
fragment assembly’
Cyclotide-containing mixtures were chemically modified
to yield S-carbamidomethylated Cys-residues and digested
to produce linear peptides amenable to fragmentation by
tandem MS. Completely reduced and alkylated samples
were digested using single enzymes or combinations of
trypsin, endo-GluC and chymotrypsin. Resulting mass
584 H. Hashempour et al.
123
spectra were manually analysed by assigning N-terminal b-
and C-terminal y-ions. Most novel cyclotide sequences
were independently confirmed by automatic database
searches using the ERA-tool (Colgrave et al. 2010) and
DeNovoExplorer software.
Cyclotide sequences are generally obtained from pure
peptides by enzymatic digestion and interpretation of
tandem mass spectra. For co-eluting Mo¨bius cyclotides in
mixtures, such as vigno 1 and vigno 2 (Fig. 2), it was
possible to obtain the full, unambiguous sequences by
evaluating the ion-fragmentation pattern and by alignment
of two independent digests using trypsin or endo-GluC
(Fig. 3; Supplementary Table S1). In cases where single
digests yielded incomplete fragment ion coverage, a
combination of trypsin and endo-GluC digests was
applied to generate smaller fragments and their analysis
enabled complete sequence interpretation as shown for
vigno 3 and 4 (Fig. 4, Supplementary Fig. S1; Supple-
mentary Table S1). This procedure of reduction, alkyl-
ation and enzymatic digest provided also good sequence
coverage of other Mo¨bius cyclotides in mixtures namely
varv A and vigno 5 (Supplementary Fig. S2; Supple-
mentary Table S1).
By contrast, this methodology did not yield evaluable
mass spectra for bracelet cyclotides. A linearized bracelet
cyclotide using endo-GluC very often results in incomplete
fragmentation making it impossible to assign. Tryptic
digests of fractions containing multiple bracelet cyclotides
on the other hand resulted in unclear fragmentation patterns
due to multiple enzyme cleavage sites and hence fragment-
ion overlay. Since cyclotides of the bracelet subfamily
often contain multiple basic residues (Arg and Lys), a
tryptic digest typically yields fragments corresponding to
single, double or multiple cleaved peptides (Supplementary
Table S2). Due to the high sequence homology of cyclo-
tides, the same fragment sequence may appear in more than
one peptide and, therefore, in cyclotide mixtures these
fragments have the same mass. To circumvent this prob-
lem, single and double digests combining chymotrypsin
and endo-GluC were performed. This resulted in peptide
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Fig. 2 HPLC fractionation of
cyclotides from Viola ignobilis
extract. Analytical HPLC traces
of the 50 % (a) and 80 %
(b) ethanolic solid-phase
extracts yielding seven
cyclotide-containing
subfractions (labelled 1–7).
(c) MALDI-TOF/TOF spectrum
of fraction 1 indicating the
masses of several cyclotides
including the most abundant
Mo¨bius cyclotides vigno 1 and
vigno 2, which are co-eluting
(d) on analytical HPLC
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fragments of distinct molecular weight. By combining the
sequence information from the tryptic fragments and
alignment of the distinct fragments it was possible to
assemble the full cyclotide sequence (Figs. 5, 6; Supple-
mentary Fig. S3, Supplementary Fig. S4). Finally each
sequence had to be confirmed by assignment of the line-
arized endo-GluC digested cyclotides. Exemplarily, a
flowchart of the sequence fragment assembly approach and
the sequence elucidation of the bracelet cyclotide vigno 6
have been presented (Figs. 5, 6). The tryptic digest of
fraction 5 or 6 (Fig. 2b) leads to the two fragments of
2,711.9 and 3,290.1 Da that may originate from several
cyclotides, e.g., vigno 6, vigno 8 or cycloviolacin O2
(Supplementary Table S2). On the other hand, the chy-
motrypsin digest and a combination of chymotrypsin and
endo-GluC yields fragments with distinct molecular
weights and by combining the sequence information from
the tryptic peptides with alignment of the chymotrypsin/
endo-GluC fragments it was possible to assemble the full
sequence.
Table 1 shows all cyclotide sequences from V. ignobilis
that were elucidated by the sequence fragment assembly
approach. The combination of several single and double
digests of fractions containing multiple cyclotides and the
alignment of partial sequences and assembling of peptide-
specific fragments allowed the discrimination and
unambiguous assignment and elucidation of the distinct
cyclotide sequences. This approach ultimately led to the
identification of 13 novel cyclotides, whereof ten display
previously unknown sequences (Table 1). The use of
multiple enzymes and varying combinations thereof toge-
ther with MALDI-TOF/TOF analysis will overcome major
limitations of cyclotide de novo sequencing and facilitate
the discovery of novel sequences within peptide mixtures.
MS/MS spectra and summaries of all digested fragments
used for the sequence determination of all cyclotides from
V. ignobilis are available as Supplementary Data (Supple-
mentary Fig. S1, Supplementary Fig. S2, Supplementary
Fig. S3, Supplementary Fig. S4, Supplementary Table S1,
Supplementary Table S2). To identify cyclotides in mix-
tures using MALDI-TOF/TOF analysis is a powerful tool
for an efficient sequence elucidation and the discovery of
novel cyclotide sequences. The identification of ten novel
cyclotides from V. ignobilis supports the evidence that
cyclotides are one of the largest peptide classes within
plants with immense sequence diversity in their inter-cys-
teine loops built around the stable CCK frame (Supple-
mentary Fig. S5).
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Fig. 3 MALDI-TOF/TOF sequencing of co-eluting vigno 1 and 2.
MS/MS spectra of the precursor masses of 3,227.3 Da (a) and 3,289.1 Da
(b) of a tryptic digest (reduced and S-carbamidomethylated) of fraction 1
(see Fig. 2) is shown. Observed C-terminal y- and N-terminal b-ions
that allowed sequence characterization are labelled
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Sequence variation of novel vigno cyclotides
The 13 identified peptides from Viola ignobilis belong to
both subfamilies (Table 1). One Mo¨bius cyclotide, known
as varv peptide A, has been previously isolated from Viola
arvensis (Claeson et al. 1998), as well as two bracelet
cyclotides, known as cycloviolacin O2 and O9, have been
originally found in Viola odorata (Craik et al. 1999). This
is not surprising since some cyclotides such as varv peptide
E (=cycloviolacin O12), occur in many different Viola
species such as V. tricolor, V. odorata, V. arvensis,
V. bashoanensis, V. yedoensis and V. abyssinica and,
therefore, seem to be genus-specific. Besides these rather
rare examples of inter-genus identity, each single plant
species seems to express an abundant array of specific
cyclotides. In V. ignobilis the most abundant Mo¨bius cy-
clotides are vigno 1 and vigno 2. Sequence analysis of
these two peptides revealed the presence of an AGGT
motif in loop 2 which was recently also described for
V. abyssinica cyclotides (Yeshak et al. 2011).
Besides the conserved six Cys-residues and the glutamic
acid (E) in loop 1, all six Mo¨bius cyclotides have the same
typical GET motif in loop 1 and a serine in loop 4, which is
conserved within all newly identified cyclotides from
V. ignobilis. Furthermore, the GES motif in loop 1 and the
VWIP motif in loop 2 are conserved within all bracelet
cyclotides from V. ignobilis. The differences and novelties
are within loop 3, 5 and 6 which are known to show the
highest amino-acid variability (Supplementary Fig. S5;
Table 1). For vigno 2 a novel sequence motif for loop 6 of
cyclotides, VRDGSSPL, has been discovered. Although all
amino acids are known to occur in this loop, the presence
of two serine residues next to each other has not been
reported hitherto. The presence of two serine residues and
an aspartic acid makes this loop more hydrophilic and
confers the peptide with an overall net charge of -1.
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Fig. 4 MALDI-TOF/TOF identification of the co-eluting peptides
vigno 3 and vigno 4. The difference of 14 Da can be observed in
crude (a) and within the combined trypsin and endoproteinase GluC
digest (b) of fraction 4. MS/MS sequencing of the endo-GluC/trypsin-
digested precursors with 2430.9 Da (c) and 2416.9 Da (d), respec-
tively, allowed unambiguous assignment of the sequences of these
two peptides
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Sequence confirmation: single EndoGluC digest 
(discrimination of I/L   by chymotrypsin fragments and/or amino acid analysis)
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and MS/MS de novo sequencing
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Fig. 5 Sequence fragment assembly approach for vigno 6. a An
overview of the sequence fragment assembly workflow that has been
used to elucidate cyclotide sequences in mixtures is presented. b The
combination of single trypsin, chymotrypsin and endoproteinase GluC
and a combination of chymotrypsin/endo-GluC digests of fractions
containing multiple cyclotides together with the alignment of partial
sequences and assembling of peptide-specific fragments allowed the
discrimination and unambiguous assignment and elucidation of the
cyclotide sequences. MS spectra of four digests using endo-GluC
(upper left panel), chymotrypsin (upper right), trypsin (lower left) and
a combination of endoproteinase GluC and chymotrypsin (lower
right) are shown for vigno 6. The cleavage sites and resulting peptide
fragments of the different enzymes are indicated by arrows (trypsin:
blue/dashed line, chymotrypsin: green/dotted line, endo-GluC: red/
straight line). The alignment of obtained MS sequence fragments
(middle) together with MS/MS sequence data of selected precursors
(see Fig. 6) allows the unambiguous sequence elucidation of the
novel cyclotide vigno 6 (color figure online)
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Fig. 6 MS/MS sequencing of vigno 6. Three MS/MS spectra of (a,
b) the precursors with the molecular weight of 2,711.9 and
3,290.1 Da, respectively, from a tryptic digest and (c) the linearized
cyclotide precursor with a molecular weight of 3,265.4 Da from an
endoproteinase GluC digest are shown. The sequences were obtained
by assigning the y- and b-ions series
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To distinguish between Asn and Asp residues in loop 6 of
vigno 2 and vigno 10, we have additionally analysed the
molecular weight and isotopic distribution of diagnostic
fragment ions (Poth et al. 2010) (Supplementary Figure
S6). Further sequencing of the co-eluting Mo¨bius cyclo-
tides vigno 3 and vigno 4 (Fig. 2) revealed the presence of
an alanine or glycine within loop 3 and corresponds to the
mass difference of 14 Da in the crude sample (Fig. 4a). A
combined digest using trypsin and endo-GluC yields the
fragments of 2,416.9 and 2,430.9 Da that allowed the
sequence determination and confirming the difference of a
glycine (NTPG) and alanine (NTPA) at the last position of
loop 3. This is to our knowledge the first report of an
alanine residue at this position and expands the known
possibilities at this position which was primarily thought to
be a conserved glycine (Craik et al. 1999). Within the
sequence of vigno 5 a glycine at the first position of loop 5
was found, which so far has only been shown for bracelet
cyclotides such as cycloviolacin Y1-3 (Wang et al. 2008a)
and tricyclon A and B (Mulvenna et al. 2005). Vigno 6
shows the very common KSKV sequence for loop 5, which
is intersected by a glycine, KGSKV. The identification of
ten novel peptides underlines the high flexibility and
sequence variability caused by single amino acid changes
at various positions. It is obvious that sequence variability
accounts for different biological and chemical behaviour
due to varying physico-chemical properties. As an exam-
ple, we decided to characterize the in vitro oxidative
refolding properties of representative vigno cyclotides,
since it is a valuable model to analyse their sequence-
folding relationship, which has broader implications on the
synthesis and design of cyclotides as tools in pharmaceu-
tical applications.
Sequence-folding relationship of novel vigno cyclotides
The influence of certain residues on oxidative folding and
the correct formation of the native disulfide bonds of cy-
clotides are still not fully understood. In the current study it
has been our particular interest to elucidate the sequence-
folding relationships of three vigno cyclotides with respect
to their yield and folding kinetics using different folding
conditions. Therefore, the oxidative refolding of the most
abundant Mo¨bius cyclotides in V. ignobilis, vigno 1 and
vigno 2 was studied, in comparison to the prototypic
cyclotide kalata B1, and the bracelet cyclotide vigno 10 in
comparison to cycloviolacin O2, a well-studied bracelet
cyclotide isolated from V. odorata.
To provide material for the folding studies all three
vigno cyclotides and the control cyclotides kalata B1 and
cycloviolacin O2 were purified and reduced. All native and
reduced peptides were analysed by MALDI-MS and RP-
HPLC confirming their high purity ([95 %) and the cys-
teine oxidation state (Fig. 7, Supplementary Fig. S7, Sup-
plementary Table S3). As expected the reduced cyclotides
showed a mass shift of 6 Da on MALDI-MS, indicating the
complete reduction of the three native disulfide bonds. This
results in decreased overall hydrophobicity and hence the
peptides eluted significantly earlier from the reversed-
phase column (Fig. 7f).
Table 1 Sequence alignment of cyclotides identified from Viola ignobilis
a Isobaric amino acids Leu/Ile were assigned based on chymotrypsin digests (see Supplementary Figures S9 and S10) or based on homology to
published sequences; novel sequence motifs are highlighted in bold
b Cycloviolacin
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Based on previous studies on kalata B1 (Daly et al.
1999) buffers containing 0.1 M ammonium-bicarbonate
buffer with low (25 %) and high (75 %) concentration of
isopropanol were used in the initial folding studies. High
concentrations of alcohol were recently shown to favour
folding of a bracelet cyclotide (Wong et al. 2011). In
addition, a buffer containing 35 % DMSO and 5 % dode-
cyl-b-maltoside (DBM) was used; it has been shown for
cycloviolacin O2 that a buffer containing DMSO and a
non-ionic detergent yields reasonable amounts of folded
peptide (Leta Aboye et al. 2008). All buffers contained the
disulfide shuffling redox agents reduced (GSH) and oxi-
dized (GSSG) glutathione. After dissolving the reduced
peptides, the refolding process was monitored by taking
aliquots at several time-points (15 min, 1 and 24 h). After
24 h incubation at 20 C, refolding was stopped by
quenching the reaction with concentrated TFA and samples
were subjected to RP-HPLC (Fig. 7; Supplementary Fig.
S7) and MALDI-MS analysis (Supplementary Table S3).
Generally refolding starts immediately after the reduced
peptides have been dissolved in the folding buffer, which
can be determined by disappearance of the peak in the
HPLC chromatograms corresponding to the reduced cy-
clotides. Refolding data were analysed by measuring the
area under curve of the peaks corresponding to the reduced
and native peptides and plotting the folding yields in per-
centage versus time of incubation (Fig. 7, Supplementary
Fig. S7; Table 2). In particular for the Mo¨bius cyclotides
one can observe an increase of the peak corresponding to
the native cyclotide after 15 min and the final yield was
measured after 24 h of folding. As listed in Table 2,
folding of the Mo¨bius cyclotides vigno 1, vigno 2 and
kalata B1 led to respectable yields between *30 and 90 %
of refolded peptides, favoured by higher isopropanol con-
centrations versus the DMSO/detergent buffer. This is
consistent with previous studies and the fact that the
hydrophobic solvent appears to stabilize the surface
exposed hydrophobic patches of cyclotides (Daly et al.
1999). To compare the folding kinetics of each cyclotide
the rate constant (kn) and the half-time (t1/2) of appearance
of the native species were calculated. For the three Mo¨bius
cyclotides the half-time of appearance of the native peak
was between 25 and 96 min (Table 2). Folding of bracelet
cyclotides appears to be more complex and difficult under
in vitro conditions as has previously been reported (Aboye
et al. 2011; Gunasekera et al. 2009). Accordingly, the
overall refolding yield of the bracelet cyclotides vigno 10
and cycloviolacin O2 in the two isopropanol buffers or the
standard DMSO/detergent buffer (=35 % DMSO/5 %
DBM in 0.1 M NH4HCO3 with GSH/GSSG) was signifi-
cantly lower (*10–14 %) (Table 2). Go¨ransson et al. have
previously studied folding of cycloviolacin O2 and
achieved *40 % of native peptide (Leta Aboye et al.
2008), which is higher than what has been observed in
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Fig. 7 Refolding of cyclotides. RP-HPLC traces of native, reduced
and refolded peptides under conditions leading to the highest yields of
vigno 1 (a), vigno 2 (b), vigno 10 (c), kalata B1 (d) and cycloviolacin
O2 (e) are offset aligned for clarity. The folding of vigno peptides and
kalata B1 (a–d) was performed in 0.1 M NH4HCO3 at 20 C and
cycloviolacin O2 (e) folding was carried out in Tris-buffer at 4 C
(see ‘‘Materials and methods’’ for further details). f Difference in
hydrophobicity of all peptides used in this study is shown
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this study using the DMSO/detergent buffer (11.4 %).
However, their folding conditions were slightly different,
i.e., (1) use of Brij 35 instead of DBM, (2) use of 2 mM
cystamine in addition to GSH as redox component, (3) use
of Tris instead of NH4HCO3-buffer, (4) folding tempera-
ture of 4 C as well as 20 C and (5) folding was allowed
to proceed for 48 h with addition of fresh redox compo-
nents after 24 h. To further analyse the influence of these
differences folding of the control cyclotide cycloviolacin
O2 in each folding condition was performed and in
agreement with Go¨ransson et al. we obtained the highest
folding yield at 4 C using the Tris-buffered 35 % DMSO/
6 % Brij 35 after 48 h of folding (Table 2). In particular,
the longer incubation time and lower temperature appeared
to enhance the yield of natively folded cycloviolacin O2.
Figure 7 shows the HPLC chromatograms of the highest
yielding folding conditions for each cyclotide.
Comparison of the sequences and structures provides
insights into the differences observed in the folding
efficiency in terms of yield and kinetics. Vigno 1 and vigno
2 have high sequence similarity to kalata B1, and all three
peptides have high folding yields in 75 % isopropanol
buffer (Table 2). However, there are differences in folding
using the 25 % isopropanol and 35 % DMSO/detergent
buffers (Table 2). The three Mo¨bius peptides differ in loop
6, i.e., VRNGLPL in vigno 1, VRDGSSPL in vigno 2 and
TRNGLPV in kalata B1 (Table 2; Supplementary Fig. S8).
The two adjacent serine residues and an aspartic acid in
vigno 2 make this loop more hydrophilic and confers the
peptide an overall single negative net charge. This may
explain higher folding yields of vigno 2 for the 25 % iso-
propanol buffer and lower yields for the more hydrophobic
75 % isopropanol buffer as compared to vigno 1, a neutral
cyclotide. The more hydrophilic nature of loop 6 of vigno 2
(Supplementary Fig. S8) (Aboye et al. 2011) may also
contribute to the different folding yields in the DMSO/
detergent buffer, which vary between 62.7 % for vigno 1,
30.5 % for vigno 2 and 87 % for the control peptide kalata
Table 2 Overview of yields and folding kinetics of vigno cyclotides
Cyclotidea Bufferb Yieldc (%) Folding kineticsd
kn (min
-1) t1/2 (min) R
2
Vigno 1 25 % isopropanol (aqueous) 28.9 0.007 95.6 0.99
75 % isopropanol (aqueous) 89.8 0.012 55.7 [0.99
35 % DMSO/5 % dodecyl-b-maltoside (DBM) 62.7 0.010 69.6 0.93
Vigno 2 25 % isopropanol (aq.) 52.2 0.013 54.1 0.97
75 % isopropanol (aq.) 80.4 0.027 25.6 0.99
35 % DMSO/5 % DBM 30.5 0.015 46.1 0.89
Kalata B1 25 % isopropanol (aq.) 88.6 0.021 32.3 0.96
75 % isopropanol (aq.) 87.7 0.018 37.7 0.99
35 % DMSO/5 % DBM 87.0 0.009 75.2 [0.99
Vigno 10 25 % isopropanol (aq.) 1.3 –e – –
75 % isopropanol (aq.) 11.4 – – –
35 % DMSO/5 % DBM 1.0 – – –
Cycloviolacin O2 25 % isopropanol (aq.) 6.3 – – –
75 % isopropanol (aq.) 13.5 – – –
35 % DMSO/5 % DBM 11.4 – – –
35 % DMSO/5 % DBMf 13.0 0.028 24.6 –
35 % DMSO/6 % Brij35 (Tris, 4 C)f 15.2/28.7 g 0.008 92.4 [0.99
35 % DMSO/6 % Brij35 (Tris, 20 C)f 9.2/20.6 g 0.032 21.7 0.99
a All folding experiments were carried out with peptide concentrations between 2.5 and 10 lM
b All buffers were prepared in 0.1 M NH4HCO3 (pH 8.2) with GSH/GSSG (2/0.1 mM) except where indicated otherwise
c Final yield after 24 h incubation at 20 C; determined by automatic peak integration with a peak threshold set at 0.07 3 signal (mAU) 9 RT
(min) using Chromeleon software 6.8
d Rate constant of native folded peptide (kn) and folding half-time of observed folding yields determined by single exponential fit using
GraphPad Prism 5, calculated over 24 h
e Not determined
f Buffer containing GSH/cystamine (2/2 mM)
g Yield after 48 h incubation, with addition of fresh GSH/cystamine (2/2 mM) after 24 h
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B1. Furthermore, loop 2 of vigno 1 and 2 are very similar;
they both have a slightly more hydrophobic nature com-
pared to kalata B1 (Supplementary Fig. S8), which prob-
ably also contributes to the folding differences and the
overall later elution on RP-HPLC (Fig. 7f).
Analysis of the folding of the bracelet cyclotide vigno
10 highlights the complexity of the oxidative folding of this
cyclotide sub-family. The folding yields of vigno 10 and
cycloviolacin O2 in the 75 % isopropanol buffer were
comparable (13.5 vs. 11.4 %, respectively), but consider-
ably lower than that observed for the Mo¨bius cyclotides.
Interestingly, the use of the DMSO/detergent buffer did not
increase the yield of correctly folded vigno 10, but in fact
resulted in negligible amounts of the native fold. By con-
trast, this buffer resulted in approximately 11 % of the
correctly folded cycloviolacin O2. Comparison of the
sequences reveals that only loops 3 and 6 differ between
vigno 10 and cycloviolacin O2. Loop 3 differs by two
residues and loop 6 of vigno 10 is a hybrid between the
loop 6 sequences of cycloviolacin O2 and kalata B8. Loop
3 forms a helical structure in bracelet cyclotides, and has
previously been suggested to be important in the folding of
cycloviolacin O2 (Go¨ransson et al. 2009; Leta Aboye et al.
2008). The introduction of two valine residues in loop 3 of
vigno 10, which does not favour the formation of helices,
may account for slight distortion in this region of vigno 10
(Fig. 8). A study involving the synthesis of hybrids of
kalata B1 and cycloviolacin O1 indicated that bracelet
loops 2 and 6 significantly influence the folding (Gunase-
kera et al. 2009). Given the loop 2 sequences of vigno 10
and cycloviolacin O2 are identical, the differences in loop
6 are also likely to be involved in the folding differences
observed for these two peptides. In the model of vigno 10
the backbone and side chain atoms of residues T2, K29 and
D30 have different orientations as compared to residues
R29 and N30 of cycloviolacin O2 (Fig. 8). These structural
changes could contribute to the decreased folding yield in
the DMSO/detergent buffer, by destabilizing a late folding
intermediate, which shifts the equilibrium towards the non-
native conformation (Leta Aboye et al. 2008). Furthermore,
loop 2 contains an isoleucine previously shown to detri-
mentally influence the oxidative folding and this residue
may, in part, be responsible for the generally lower yields
observed for vigno 10 and cycloviolacin O2 with respect to
the Mo¨bius cyclotides. Taken together, our folding studies
of the novel vigno cyclotides compared to kalata B1 and
cycloviolacin O2 confirms the significant difference of
Mo¨bius versus bracelet folding and the strong influence of
the surface characteristics of cyclotides and solution con-
ditions on their folding.
Conclusion
This work has broadened the knowledge about the
immense sequence diversity of plant cyclotides, a unique
class of naturally occurring backbone-cyclized peptides
built around a conserved cyclic cystine-knot. By charac-
terizing 13 sequences from an Iranian violet species it has
been confirmed that cyclotides are one of the most abun-
dant peptide class within the plant kingdom. The charac-
terization of cyclotides in mixtures using MALDI-TOF/
TOF analytics may overcome laborious isolation and
challenges in de novo peptide sequencing. The use of
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V19
V18
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R29
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vigno 10 TIPCGESCVWIPCISSVVGCSCKSKVCYK
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G
G
D
N
(d)
Fig. 8 Structural alignment of vigno 10 and cycloviolacin O2. The
structures of cycloviolacin O2 (cyan PDB code: 2GJ0) and the
homology model of vigno 10 (green) were aligned using PyMOL
(root-mean-square deviation = 1.324 A˚) and are shown in cartoon
representation (a). The cyclotide loops and disulfide bonds (yellow)
are indicated. Differences in the side-chain orientation of the distinct
residues of both cyclotides of loop 3 (b) and loop 6 (c) are indicated in
stick representation and amino acids are labelled in one-letter code,
numbered according to their position in the cyclotide sequence
(starting from G1, see d). Images have been prepared using PyMOL.
(d) Sequence alignment of vigno 10 and cycloviolacin O2 with the
three conserved disulfide bridges (shown in yellow) and the cyclized
backbone (black dots and connecting line). Residues differing
between those two cyclotides have been highlighted in red (color
figure online)
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different proteases as well as the assembly and alignment
of sequence fragments facilitates the discovery of novel
cyclotide sequences. In addition, by performing oxidative
refolding studies on representative cyclotides the knowl-
edge of their in vitro oxidative folding behaviour was
extended and this underlines the high dependency of
folding yield to their inter-cysteine loop sequences and
careful choice of the folding conditions. These studies have
further implications taking into account that cyclotides
have numerous bioactivities and hence display a scaffold
that is extensively used for peptide-based drug design.
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